10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer McAnear Justin J.
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.65%)
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(16.252%),Abigail P. Johnson(16.252%)
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.5%)
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.60%)
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Saxonov Serge
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Hindson Benjamin J.
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Saxonov Serge
10x Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(3.5%)
10x Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Wilbur James
No Data